MedPath

Clinic-based evaluation of antigen-based point-of-care tests for genital trichomoniasis infection and bacterial vaginosis among women attending antenatal care facilities in Nchelenge, Zambia

Not Applicable
Recruiting
Conditions
Trichomoniasis and bacterial vaginosis
Fertility-female
Registration Number
PACTR202302766902029
Lead Sponsor
Tropical Disease Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
1021
Inclusion Criteria

1.Pregnant women confirmed by ultrasound
2.Gestational age from Week 13 and 0 Days
3.Willing and able to provide written informed consent

Exclusion Criteria

1.History of using metronidazole or clindamycin during current pregnancy
2.Known allergy or contraindication to metronidazole
3.Unable to give written informed consent
4.Previously having participated in this study
5.Have (a) used a vaginal cream or ointment product, (b) douched, or (c) used spermicides, vaginal lubricants or feminine sprays within 72 hours of testing

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.